Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does antihypertensive therapy modify chronic allograft failure?

A E Raine1

  • 1Department of Nephrology, St. Bartholomew's Hospital, London, England, United Kingdom.

Kidney International. Supplement
|December 1, 1995
PubMed
Summary

Hypertension is common after kidney transplants, impacting graft survival. Effective blood pressure control and specific antihypertensive drugs may improve long-term kidney transplant outcomes, but more research is needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maintenance of normal agonist-induced endothelium-dependent relaxation in uraemic and hypertensive resistance vessels.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1999
Same author

Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1998
Same author

Gender differences in mediators of left ventricular hypertrophy in dialysis patients.

Clinical nephrology·1998
Same author

Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients.

Clinical nephrology·1998
Same author

Interdialytic weight gain and 48-h blood pressure in haemodialysis patients.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1997
Same author

Acute reversal of cyclosporine nephrotoxicity by neutral endopeptidase inhibition in stable renal transplant recipients.

Transplantation·1997

Area of Science:

  • Nephrology
  • Transplant Medicine
  • Cardiovascular Medicine

Background:

  • Hypertension affects over 50% of renal transplant recipients, potentially reducing chronic allograft survival.
  • Poorly controlled blood pressure mirrors native kidney disease progression, suggesting a similar benefit from control in transplants.
  • The impact of different antihypertensive classes on long-term graft outcomes remains a critical, unproven question.

Purpose of the Study:

  • To explore the potential benefits of blood pressure control on chronic allograft outcomes.
  • To investigate whether specific antihypertensive medication classes offer differing long-term graft survival advantages.
  • To examine the roles of glomerular hypertension, hyperfiltration, and ischemia in chronic allograft failure.

Main Methods:

Related Experiment Videos

  • Review of existing literature on post-transplant hypertension and its effects on renal allografts.
  • Discussion of proposed mechanisms, including glomerular hypertension/hyperfiltration and ischemia.
  • Consideration of the potential roles of ACE inhibitors, calcium channel blockers, endothelin receptor antagonists, and neutral endopeptidase inhibitors.

Main Results:

  • While effective blood pressure control is presumed beneficial, prospective studies are lacking.
  • ACE inhibitors may have limited renoprotective effects in cyclosporine-treated patients due to sodium retention and renin suppression.
  • Calcium channel blockers and newer agents like endothelin receptor antagonists may offer benefits by improving renal hemodynamics.

Conclusions:

  • Effective blood pressure management is likely crucial for long-term renal allograft survival.
  • Different antihypertensive drug classes may have varying impacts on graft outcomes, necessitating further investigation.
  • Prospective, comparative studies are essential to determine the optimal antihypertensive strategies for renal transplant recipients.